Research Article
Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy
Table 4
Evaluation values in patient dynamics no. 2.
| CD3 (%) | CD4 (%) | CD8 (%) |
| 73.99 | 32.27 | 37.33 | 71.08 | 31.23 | 35.68 | 73.96 | 30.17 | 39.24 | 67.92 | 28.88 | 34.69 | 43.92 | 18.46 | 22.85 | 60.06 | 22.72 | 33.41 | 56.67 | 23.74 | 29.44 | 49.82 | 20.79 | 25.56 | 38.61 | 15.74 | 20.24 | 42.88 | 16.04 | 23.63 | 73.67 | 31.79 | 37.59 |
|
|